Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The Cancer-Immune Set Point in Oesophageal Cancer

4 Jun 2020

Abstract excerpt

Immunotherapy has achieved long-term disease control in a proportion of cancer patients, but determinants of clinical benefit remain unclear. A greater understanding of antitumor immunity on an individual basis is needed to facilitate a precision oncology approach. A conceptual framework called the "cancer-immune set point" has been proposed to describe the equilibrium between factors that promote or suppress...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Immunotherapy and Biomarkers
Share to Esophageal Cancer Research and Treatment
Share to Immune Cell Function and Interaction

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32582553
DOI: 10.3389/fonc.2020.00891

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The Cancer-Immune Set Point in Oesophageal CancerPMID 32582553Read ↗

Cancer Immunotherapy: A Focus on the Regulation of Immune CheckpointsSemantic proximity Read ↗

Immune cell‐related prognostic risk model and tumor immune environment modulation in esophageal carcinoma based on single‐cell and bulk RNA sequencingSemantic proximity Read ↗

Visceral adipose tissue secretome from early and late-stage oesophageal cancer patients differentially affects effector and regulatory T cells.Semantic proximity Read ↗

Multi-omics sequencing of gastroesophageal junction adenocarcinoma reveals prognosis-relevant key factors and a novel immunogenomic classification.Semantic proximity Read ↗

The cancer-immunity cycle: Indication, genotype, and immunotype.Semantic proximity Read ↗

Understanding Microbiome Effect on Immune Checkpoint Inhibition in Lung Cancer: Placing the Puzzle Pieces TogetherSemantic proximity Read ↗

Concepts Collide: Genomic, Immune, and Microbial Influences on the Tumor Microenvironment and Response to Cancer Therapy.Semantic proximity Read ↗

Insights into the Mechanisms of Immune‐Checkpoint Inhibitors Gained from Spatiotemporal Dynamics of the Tumor MicroenvironmentSemantic proximity Read ↗

The Resistance Mechanisms of Checkpoint Inhibitors in Solid TumorsSemantic proximity Read ↗

Phenotypic immune characterization of gastric and esophageal adenocarcinomas reveals profound immune suppression in esophageal tumor locations.Semantic proximity Read ↗

Evolutionary and immune microenvironment dynamics during neoadjuvant treatment of oesophagael adenocarcinomaSemantic proximity Read ↗

Cancer Immunotherapy Biomarkers of Response and Toxicity; Current Limitations and Future PromiseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.